The authors have used a TEM1 (Tumour endothelial marker1 is a protein expressed in the tumour-associated endothelium) vaccine together with RT and anti-PD1 antibody in subcutaneous colorectal and lung tumours and shown an effective anti-tumour response. The gene discussed is CD248; the disease is neoplasm.